Nano-enabled colorectal cancer therapy

Q Pan, X Fan, L Xie, D Wu, R Liu, W Gao, K Luo… - Journal of Controlled …, 2023 - Elsevier
Colorectal cancer (CRC), one of the most common and deadliest diseases worldwide, poses
a great health threat and social burden. The clinical treatments of CRC encompassing …

Strategies targeting tumor immune and stromal microenvironment and their clinical relevance

M Hu, L Huang - Advanced Drug Delivery Reviews, 2022 - Elsevier
The critical role of tumor microenvironment (TME) in tumor initiation and development has
been well-recognized after more than a century of studies. Numerous therapeutic …

Nano codelivery of oxaliplatin and folinic acid achieves synergistic chemo-immunotherapy with 5-fluorouracil for colorectal cancer and liver metastasis

J Guo, Z Yu, M Das, L Huang - ACS nano, 2020 - ACS Publications
FOLFOX, the combinational strategy of folinic acid (FnA), 5-fluorouracil (5-Fu), and
oxaliplatin (OxP), has been used as standard treatment of colorectal cancer (CRC) for …

Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and …

J Guo, Z Yu, D Sun, Y Zou, Y Liu, L Huang - Molecular Cancer, 2021 - Springer
Background FOLFOX is a combinational regimen of folinic acid (FnA, FOL), fluorouracil (5-
Fu, F) and oxaliplatin (OxP, OX), and has been long considered as the standard treatment of …

The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1

Y Xi, Y Li, P Xu, S Li, Z Liu, H Tung, X Cai, J Wang… - Science …, 2021 - science.org
Activation of the hepatic stellate cells (HSCs) is a key pathogenic event in liver fibrosis.
Protein S-glutathionylation (PSSG) of cysteine residues is a distinct form of oxidative …

Tumor Microenvironment Sequential Drug/Gene Delivery Nanosystem for Realizing Multistage Boosting of Cancer–Immunity Cycle on Cancer Immunotherapy

Y Cao, J Li, Q Liang, J Yang, X Zhang… - … Applied Materials & …, 2023 - ACS Publications
The antitumor immune response of cancer immunotherapy is a cascade of cancer–immunity
cycles (CIC). The immunosuppression of the tumor microenvironment and low …

Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma

L Li, Y Zou, L Wang, L Yang, Y Li, A Liao… - International Journal of …, 2023 - Elsevier
Hepatocellular carcinoma (HCC) causes the immunosuppressive tumor microenvironment
(TME) resistant to current immunotherapy. The immunogenic apoptosis (currently termed …

Rna-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer

X Zhou, D Li, S Xia, X Ma, R Li, Y Mu, Z Liu… - Journal of Controlled …, 2024 - Elsevier
Tumor-associated macrophages play pivotal roles in tumor progression and metastasis.
Macrophage-mediated clearance of apoptotic cells (efferocytosis) supports inflammation …

Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose

HC Tung, JW Kim, J Zhu, S Li, J Yan, Q Liu… - Science Translational …, 2024 - science.org
Activation of extracellular matrix–producing hepatic stellate cells (HSCs) is a key event in
liver fibrogenesis. We showed that the expression of the heme-thiolate monooxygenase …

Role of relaxin signaling in Cancer: A review

A Kotwal, WS Goldner, RG Bennett - Biochemical Pharmacology, 2024 - Elsevier
The investigation into relaxin (RLN), additional RLN-like proteins, and RLN family peptide
receptors (RXFP) has demonstrated their role in modulating the extracellular matrix (ECM) …